GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


CASE STUDIES IN MEDICINES RISK COMMUNICATION


OBJECTIVES



To analyse and discuss notable examples with special attention to the risk communication aspects

To analyse the role of media, internet, scientific journals, independent bulletin of information

To measure the effectiveness of risk communication as a minimisation strategy and consider ways of improving its effectiveness

Case study, risk medicine, drug withdrawal

 

MODULE PARTS



  1. Hepatitis B vaccine in France, pandemic influenza vaccines, HRT and cancer. What can we learn? What could have been done?
  2. Communication aspects based on drug withdrawals: e.g. rofecoxib, rosiglitazone, benfluorex. What can we learn? What could have been done?
  3. How to measure the effectiveness of risk communication

 

TRAINER TEAM



Coordinator: Dr Marie-Pierre Barrouillet (from Université de Bordeaux)

Expert(s): Dr Annie Fourrier-Réglat, Prof Bernard Bégaud, Prof Nicholas Moore (from Université de Bordeaux), Dr Paul Benkimoun (from Le Monde), Jon Cohen (from Science).

Advanced level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from June 19th, 2017 to March 23rd, 2018.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on June 19th, 2017. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners